Aspiriant LLC’s Dimensional US Equity ETF DFUS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$232K Sell
2,797
-1,281
-31% -$106K 0.01% 376
2026
Q2
$334K Hold
4,078
– – 0.01% 306
2026
Q1
$289K Hold
4,078
– – 0.01% 284
2025
Q4
$302K Hold
4,078
– – 0.01% 278
2025
Q3
$295K Hold
4,078
– – 0.01% 253
2025
Q2
$273K Hold
4,078
– – 0.01% 269
2025
Q1
$247K Hold
4,078
– – 0.01% 263
2024
Q4
$260K Hold
4,078
– – 0.01% 251
2024
Q3
$254K Hold
4,078
– – 0.01% 253
2024
Q2
$240K Hold
4,078
– – 0.01% 257
2024
Q1
$232K Hold
4,078
– – 0.01% 291
2023
Q4
$211K Buy
+4,078
New +$197K 0.01% 292
2022
Q3
– Sell
-5,684
Closed -$233K – 266
2022
Q2
$233K Sell
5,684
-540
-9% -$23.9K 0.01% 243
2022
Q1
$304K Sell
6,224
-2,467
-28% -$119K 0.02% 222
2021
Q4
$449K Buy
+8,691
New +$437K 0.02% 185

Other funds holding DFUS

Aspiriant LLC's DFUS Position: Q3 2026 in Review

Aspiriant LLC reduced its Dimensional US Equity ETF (DFUS) stake by 31% in Q3 2026, selling an estimated $106K and leaving 2,797 shares worth $232K. The position accounts for 0.01% of the portfolio, ranked #376.

Aspiriant LLC first reported a position in DFUS in Q4 2021 and has held it in 15 quarters since. The position peaked at $449K in Q4 2021. 219 funds tracked by Wall St. Rank hold DFUS as of Q3 2026.

  • Aspiriant LLC held 2,797 shares of Dimensional US Equity ETF worth $232K as of Q3 2026.
  • Aspiriant LLC sold 1,281 Dimensional US Equity ETF shares in Q3 2026, an estimated $106K.
  • Dimensional US Equity ETF made up 0.01% of Aspiriant LLC's portfolio in Q3 2026, its #376 holding.
  • Aspiriant LLC first reported a position in Dimensional US Equity ETF in Q4 2021 and has held it in 15 quarters since.
  • Aspiriant LLC's Dimensional US Equity ETF position peaked at $449K in Q4 2021.
  • 219 funds tracked by Wall St. Rank held Dimensional US Equity ETF as of Q3 2026.

Based on Aspiriant LLC's 13F filing for Q3 2026, filed 16 Oct 2026.